J. Remohı́

No ORCID on file · 12 papers in corpus
2025
·doi:10.1016/j.fertnstert.2025.07.897
2011
·doi:10.1093/humrep/26.s1.62
2005
·doi:10.1016/j.fertnstert.2005.07.767
2003
·doi:10.1016/s0015-0282(03)01514-0
review 2003
Obstetrics and Gynecology Clinics of North America ·doi:10.1016/s0889-8545(02)00060-8

Prospective and retrospective clinical trials suggest a decreased oocyte and embryo quality in women with endometriosis. Based on these observations, the authors described an altered intrafollicular milieu in endometriosis, which explains t…

other 2002
Journal of assisted reproduction and genetics ·doi:10.1023/a:1014058622697

PURPOSE: To investigate the secretion of progesterone (P4) and corticosteroid binding globulin (CBG) by granulosa luteal cells (GC) as well as the mRNA levels of CBG and 3beta hydroxisteroid dehydrogenase (3beta HSD), in women with and with…

2002
·doi:10.1016/s0015-0282(02)04087-6
observational 2000
Fertility and sterility ·doi:10.1016/s0015-0282(00)00570-7

OBJECTIVE: To evaluate the impact of severe endometriosis on IVF-ET outcome in women receiving oocytes from the-same donor. DESIGN: A matched case-control study. SETTING: Oocyte donation program at the Instituto Valenciano de Infertilidad…

1999
·doi:10.1093/humrep/14.suppl_3.4-a
1999
·doi:10.1093/humrep/14.suppl_3.181-a

and the remammg 53 were non-cycling women. Cycling recipients underwent pituitary down-regulation using GnRH analogue from the midluteal phase of the previous cycle. All patients received hormonal replacement therapy (HRT) with increasing o…

observational 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00204-0

OBJECTIVE: To assess the endocrine, paracrine, and autocrine milieu in patients with endometriosis on the basis of the measurement of several cytokines in serum and follicular fluid (FF) and in vitro culture of granulosa luteal cells. DESI…

nonrandomized-trial 1993
Fertility and sterility ·doi:10.1016/s0015-0282(16)55978-0

OBJECTIVE: To analyze endometrial response (endometrial dating and implantation) to exogenous administration of E2-valerate and P in women with low response to gonadotropins undergoing oocyte donation. DESIGN: Prospective study. A cycle in…